HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 04-FEB-17 5UPU TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE INOSINE MONOPHOSPHATE TITLE 2 DEHYDROGENASE FROM MYCOBACTERIUM TUBERCULOSIS IN THE PRESENCE OF TBK6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IMPDH,IMPDH2; COMPND 5 EC: 1.1.1.205; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 STRAIN: ATCC 25618 / H37RV; SOURCE 6 GENE: GUAB, GUAB2, RV3411C, MTCY78.17; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) MAGIC; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PMCSG7 KEYWDS IMPDH, DELTA CBS, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS KEYWDS 2 OF INFECTIOUS DISEASES, CSGID, OXIDOREDUCTASE, OXIDOREDUCTASE- KEYWDS 3 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.KIM,M.MAKOWSKA-GRZYSKA,N.MALTSEVA,R.MULLIGAN,M.GU,J.SACCHETTINI, AUTHOR 2 W.F.ANDERSON,A.JOACHIMIAK,CENTER FOR STRUCTURAL GENOMICS OF AUTHOR 3 INFECTIOUS DISEASES (CSGID) REVDAT 4 04-OCT-23 5UPU 1 REMARK REVDAT 3 01-JAN-20 5UPU 1 REMARK REVDAT 2 20-SEP-17 5UPU 1 REMARK REVDAT 1 22-FEB-17 5UPU 0 JRNL AUTH Y.KIM,M.MAKOWSKA-GRZYSKA,N.MALTSEVA,R.MULLIGAN,M.GU, JRNL AUTH 2 J.SACCHETTINI,W.F.ANDERSON,A.JOACHIMIAK, JRNL AUTH 3 CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES JRNL AUTH 4 (CSGID) JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE INOSINE JRNL TITL 2 MONOPHOSPHATE DEHYDROGENASE FROM MYCOBACTERIUM TUBERCULOSIS JRNL TITL 3 IN THE PRESENCE OF TBK6 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1745 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 6818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.570 REMARK 3 FREE R VALUE TEST SET COUNT : 380 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.9245 - 4.1889 1.00 2311 140 0.1573 0.1947 REMARK 3 2 4.1889 - 3.3256 1.00 2289 134 0.1746 0.2899 REMARK 3 3 3.3256 - 2.9055 0.80 1838 106 0.2287 0.2672 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2412 REMARK 3 ANGLE : 0.795 3284 REMARK 3 CHIRALITY : 0.022 398 REMARK 3 PLANARITY : 0.003 422 REMARK 3 DIHEDRAL : 11.789 861 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UPU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226290. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97926 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7281 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.13600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.67200 REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000, MOLREP REMARK 200 STARTING MODEL: 4ZQR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE PH 8.0, 2.5 M SODIUM REMARK 280 CHLORIDE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.30700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.30700 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.52800 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.30700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.30700 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 42.52800 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 44.30700 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 44.30700 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 42.52800 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 44.30700 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 44.30700 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 42.52800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -95.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 GLY A 4 REMARK 465 MET A 5 REMARK 465 SER A 6 REMARK 465 GLY A 7 REMARK 465 LEU A 8 REMARK 465 GLU A 9 REMARK 465 ASP A 10 REMARK 465 SER A 11 REMARK 465 SER A 12 REMARK 465 ASP A 13 REMARK 465 LEU A 14 REMARK 465 VAL A 15 REMARK 465 VAL A 16 REMARK 465 SER A 17 REMARK 465 PRO A 18 REMARK 465 TYR A 19 REMARK 465 VAL A 20 REMARK 465 ARG A 21 REMARK 465 MET A 22 REMARK 465 GLY A 23 REMARK 465 GLY A 24 REMARK 465 LEU A 25 REMARK 465 THR A 26 REMARK 465 THR A 27 REMARK 465 ARG A 431 REMARK 465 GLY A 432 REMARK 465 ARG A 433 REMARK 465 GLY A 434 REMARK 465 GLY A 435 REMARK 465 ALA A 436 REMARK 465 THR A 437 REMARK 465 SER A 438 REMARK 465 TYR A 439 REMARK 465 SER A 440 REMARK 465 LYS A 441 REMARK 465 ASP A 442 REMARK 465 ARG A 443 REMARK 465 TYR A 444 REMARK 465 PHE A 445 REMARK 465 ALA A 446 REMARK 465 ASP A 447 REMARK 465 ASP A 448 REMARK 465 ALA A 449 REMARK 465 LEU A 450 REMARK 465 SER A 451 REMARK 465 GLU A 452 REMARK 465 ASP A 453 REMARK 465 LYS A 454 REMARK 465 LEU A 455 REMARK 465 LYS A 510 REMARK 465 GLU A 511 REMARK 465 SER A 512 REMARK 465 HIS A 513 REMARK 465 PRO A 514 REMARK 465 HIS A 515 REMARK 465 ASP A 516 REMARK 465 VAL A 517 REMARK 465 ALA A 518 REMARK 465 MET A 519 REMARK 465 THR A 520 REMARK 465 VAL A 521 REMARK 465 GLU A 522 REMARK 465 ALA A 523 REMARK 465 PRO A 524 REMARK 465 ASN A 525 REMARK 465 TYR A 526 REMARK 465 TYR A 527 REMARK 465 ALA A 528 REMARK 465 ARG A 529 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 28 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 31 -2.42 -54.50 REMARK 500 THR A 71 -167.89 -123.14 REMARK 500 PRO A 79 45.91 -77.05 REMARK 500 VAL A 88 -62.71 -127.02 REMARK 500 ASN A 109 48.38 -94.99 REMARK 500 VAL A 282 97.02 -69.38 REMARK 500 ALA A 315 -3.34 -145.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6Q9 A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZQM RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE PRESENCE OF XMP AND NAD REMARK 900 RELATED ID: 4ZQN RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE PRESENCE OF IMP AND P41 REMARK 900 RELATED ID: 4ZQO RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE PRESENCE OF IMP AND Q67 REMARK 900 RELATED ID: 4ZQP RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE PRESENCE OF IMP AND MAD1 REMARK 900 RELATED ID: 4ZQR RELATED DB: PDB REMARK 900 THE SAME PROTEIN, APP-FORM REMARK 900 RELATED ID: CSGID-IDP91646 RELATED DB: TARGETTRACK REMARK 900 RELATED ID: 5UPV RELATED DB: PDB DBREF 5UPU A 1 125 UNP P9WKI7 IMDH_MYCTU 1 125 DBREF 5UPU A 256 529 UNP P9WKI7 IMDH_MYCTU 256 529 SEQADV 5UPU SER A -2 UNP P9WKI7 EXPRESSION TAG SEQADV 5UPU ASN A -1 UNP P9WKI7 EXPRESSION TAG SEQADV 5UPU ALA A 0 UNP P9WKI7 EXPRESSION TAG SEQADV 5UPU GLY A 126 UNP P9WKI7 LINKER SEQADV 5UPU GLY A 127 UNP P9WKI7 LINKER SEQADV 5UPU LEU A 253 UNP P9WKI7 LINKER SEQADV 5UPU LEU A 254 UNP P9WKI7 LINKER SEQADV 5UPU VAL A 255 UNP P9WKI7 LINKER SEQRES 1 A 407 SER ASN ALA MET SER ARG GLY MET SER GLY LEU GLU ASP SEQRES 2 A 407 SER SER ASP LEU VAL VAL SER PRO TYR VAL ARG MET GLY SEQRES 3 A 407 GLY LEU THR THR ASP PRO VAL PRO THR GLY GLY ASP ASP SEQRES 4 A 407 PRO HIS LYS VAL ALA MET LEU GLY LEU THR PHE ASP ASP SEQRES 5 A 407 VAL LEU LEU LEU PRO ALA ALA SER ASP VAL VAL PRO ALA SEQRES 6 A 407 THR ALA ASP THR SER SER GLN LEU THR LYS LYS ILE ARG SEQRES 7 A 407 LEU LYS VAL PRO LEU VAL SER SER ALA MET ASP THR VAL SEQRES 8 A 407 THR GLU SER ARG MET ALA ILE ALA MET ALA ARG ALA GLY SEQRES 9 A 407 GLY MET GLY VAL LEU HIS ARG ASN LEU PRO VAL ALA GLU SEQRES 10 A 407 GLN ALA GLY GLN VAL GLU MET VAL LYS ARG SER GLY GLY SEQRES 11 A 407 LEU LEU VAL GLY ALA ALA VAL GLY VAL GLY GLY ASP ALA SEQRES 12 A 407 TRP VAL ARG ALA MET MET LEU VAL ASP ALA GLY VAL ASP SEQRES 13 A 407 VAL LEU VAL VAL ASP THR ALA HIS ALA HIS ASN ARG LEU SEQRES 14 A 407 VAL LEU ASP MET VAL GLY LYS LEU LYS SER GLU VAL GLY SEQRES 15 A 407 ASP ARG VAL GLU VAL VAL GLY GLY ASN VAL ALA THR ARG SEQRES 16 A 407 SER ALA ALA ALA ALA LEU VAL ASP ALA GLY ALA ASP ALA SEQRES 17 A 407 VAL LYS VAL GLY VAL GLY PRO GLY SER ILE CYS THR THR SEQRES 18 A 407 ARG VAL VAL ALA GLY VAL GLY ALA PRO GLN ILE THR ALA SEQRES 19 A 407 ILE LEU GLU ALA VAL ALA ALA CYS ARG PRO ALA GLY VAL SEQRES 20 A 407 PRO VAL ILE ALA ASP GLY GLY LEU GLN TYR SER GLY ASP SEQRES 21 A 407 ILE ALA LYS ALA LEU ALA ALA GLY ALA SER THR ALA MET SEQRES 22 A 407 LEU GLY SER LEU LEU ALA GLY THR ALA GLU ALA PRO GLY SEQRES 23 A 407 GLU LEU ILE PHE VAL ASN GLY LYS GLN TYR LYS SER TYR SEQRES 24 A 407 ARG GLY MET GLY SER LEU GLY ALA MET ARG GLY ARG GLY SEQRES 25 A 407 GLY ALA THR SER TYR SER LYS ASP ARG TYR PHE ALA ASP SEQRES 26 A 407 ASP ALA LEU SER GLU ASP LYS LEU VAL PRO GLU GLY ILE SEQRES 27 A 407 GLU GLY ARG VAL PRO PHE ARG GLY PRO LEU SER SER VAL SEQRES 28 A 407 ILE HIS GLN LEU THR GLY GLY LEU ARG ALA ALA MET GLY SEQRES 29 A 407 TYR THR GLY SER PRO THR ILE GLU VAL LEU GLN GLN ALA SEQRES 30 A 407 GLN PHE VAL ARG ILE THR PRO ALA GLY LEU LYS GLU SER SEQRES 31 A 407 HIS PRO HIS ASP VAL ALA MET THR VAL GLU ALA PRO ASN SEQRES 32 A 407 TYR TYR ALA ARG HET IMP A 601 23 HET 6Q9 A 602 20 HETNAM IMP INOSINIC ACID HETNAM 6Q9 ~{N}-(2~{H}-INDAZOL-6-YL)-3,5-DIMETHYL-1~{H}-PYRAZOLE- HETNAM 2 6Q9 4-SULFONAMIDE FORMUL 2 IMP C10 H13 N4 O8 P FORMUL 3 6Q9 C12 H13 N5 O2 S FORMUL 4 HOH *5(H2 O) HELIX 1 AA1 THR A 46 ASP A 48 5 3 HELIX 2 AA2 GLU A 90 ALA A 100 1 11 HELIX 3 AA3 PRO A 111 ARG A 124 1 14 HELIX 4 AA4 GLY A 262 ALA A 275 1 14 HELIX 5 AA5 ASN A 289 GLY A 304 1 16 HELIX 6 AA6 THR A 316 ALA A 326 1 11 HELIX 7 AA7 THR A 342 ALA A 347 1 6 HELIX 8 AA8 PRO A 352 ARG A 365 1 14 HELIX 9 AA9 PRO A 366 GLY A 368 5 3 HELIX 10 AB1 TYR A 379 ALA A 389 1 11 HELIX 11 AB2 PHE A 412 LYS A 416 5 5 HELIX 12 AB3 SER A 426 MET A 430 5 5 HELIX 13 AB4 PRO A 469 THR A 488 1 20 HELIX 14 AB5 THR A 492 GLN A 497 1 6 HELIX 15 AB6 THR A 505 LEU A 509 5 5 SHEET 1 AA1 2 VAL A 50 LEU A 52 0 SHEET 2 AA1 2 PHE A 501 ARG A 503 -1 O VAL A 502 N LEU A 51 SHEET 1 AA2 2 SER A 68 GLN A 69 0 SHEET 2 AA2 2 ARG A 75 LEU A 76 -1 O LEU A 76 N SER A 68 SHEET 1 AA3 9 LEU A 80 SER A 82 0 SHEET 2 AA3 9 MET A 103 LEU A 106 1 O MET A 103 N SER A 82 SHEET 3 AA3 9 GLY A 256 VAL A 259 1 O GLY A 256 N LEU A 106 SHEET 4 AA3 9 VAL A 279 ASP A 283 1 O VAL A 281 N ALA A 257 SHEET 5 AA3 9 GLU A 308 VAL A 314 1 O GLU A 308 N LEU A 280 SHEET 6 AA3 9 ALA A 330 VAL A 333 1 O LYS A 332 N GLY A 311 SHEET 7 AA3 9 VAL A 371 ASP A 374 1 O ILE A 372 N VAL A 333 SHEET 8 AA3 9 THR A 393 LEU A 396 1 O MET A 395 N ALA A 373 SHEET 9 AA3 9 LEU A 80 SER A 82 1 N VAL A 81 O LEU A 396 SHEET 1 AA4 3 LEU A 410 ILE A 411 0 SHEET 2 AA4 3 TYR A 418 ARG A 422 -1 O TYR A 418 N ILE A 411 SHEET 3 AA4 3 GLU A 461 PRO A 465 -1 O GLY A 462 N TYR A 421 CISPEP 1 GLY A 312 ASN A 313 0 -0.17 SITE 1 AC1 17 SER A 83 MET A 85 SER A 339 ILE A 340 SITE 2 AC1 17 CYS A 341 ASP A 374 GLY A 375 GLY A 376 SITE 3 AC1 17 GLY A 397 SER A 398 TYR A 421 GLY A 423 SITE 4 AC1 17 MET A 424 GLY A 425 GLU A 458 GLY A 459 SITE 5 AC1 17 6Q9 A 602 SITE 1 AC2 9 ASP A 283 ALA A 285 GLY A 334 VAL A 335 SITE 2 AC2 9 GLY A 336 THR A 343 MET A 424 GLY A 425 SITE 3 AC2 9 IMP A 601 CRYST1 88.614 88.614 85.056 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011285 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011285 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011757 0.00000